Target intelligence / Profile preview

Staphylococcus aureus surface antigen (null)

Target
null
Molecular classification
Other (Surface protein), Adhesin, Receptor (for some individual antigens, e.g. Isd proteins), Enzyme (for some individual cell wall-associated enzymes)
01

Overview

"Staphylococcus aureus surface antigens" is not a single target, but refers to a diverse group of proteins expressed on the bacterial surface, most of which are covalently attached to the cell wall peptidoglycan via sortase A-mediated anchoring.[3][7] These include families like MSCRAMMs (e.g., clumping factors, fibronectin-binding proteins), iron-regulated surface determinants (Isd proteins), protein A (SpA), and other adhesion and immune-evasion molecules.[3][7] Surface antigens mediate critical functions in infection such as adherence to host tissues, immune evasion via binding immunoglobulins or inhibiting complement, biofilm formation, and nutrient acquisition.[3][4][5] These proteins are primary mediators of S. aureus's pathogenicity and are considered major candidate targets for vaccines and anti-infective therapies, although antigenic diversity and redundancy present significant therapeutic challenges.[6][5][7] **Important notes regarding correctness**: - "Staphylococcus aureus surface antigens" is not a single defined molecule, but a heterogeneous group of membrane-associated and covalently attached proteins (the "target" is overly broad and unspecific for most therapeutic cataloguing purposes).[3][7] - For structured information, each major S. aureus surface antigen (e.g., Protein A, ClfA, IsdA/B/H) is best considered as an individual target, each with distinct properties, functions, and druggability profiles.[7][3][9] - Numerous efforts exist to develop vaccines or drugs targeting one or more of these antigens, with mixed results due to redundancy and immune variability.[5][6][7]

Other names
Cell wall-anchored protein (generic class)MSCRAMM (Microbial surface component recognizing adhesive matrix molecules; for a major subgroup)S. aureus surface protein (generic class)
02

Mechanism of action

Antibody targeting of these antigens can block adhesion or promote opsonization Prevention of immune evasion, enhancing clearance by phagocytes Inhibition of biofilm formation (anti-adhesion strategy)

03

Biological functions

Immune evasionAdhesion to host cells and tissuesInvasion of host cellsBiofilm formationIron acquisitionModulation of host inflammatory signaling
04

Disease associations

InfectionImmune evasion in infection
05

Safety considerations

High antigenic variability among strains, limiting universal vaccine/drug efficacy[6]Potential induction of non-protective or even pathogenic immune responses (e.g., protein A can stimulate non-specific B-cell activation)[1]Some antigens are essential for commensalism as well as pathogenesis, posing risk of disturbing host-microbe balance
06

Interacting drugs

There are no approved drugs targeting the entire group directly, but several proteins have been pursued as vaccine antigens or for antibody-based therapies, including:

3 more in the full profile.

07

Biomarkers

Serum anti-surface antigen antibodies (for colonization or exposure monitoring)[6]Presence of specific surface protein genes (for molecular typing of S. aureus)

Beyond the preview

Go deeper on Staphylococcus aureus surface antigen (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Staphylococcus aureus surface antigen (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call